Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2013, Article ID 297120, 2 pages
http://dx.doi.org/10.1155/2013/297120
Editorial

Human Monoclonal Antibodies as a New Class of Antiinfective Compounds

1Medical School, Università Vita-Salute San Raffaele, 20132 Milan, Italy
2GeNeuro SA, 1228 Geneva, Switzerland
3Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA

Received 1 August 2013; Accepted 1 August 2013

Copyright © 2013 Roberto Burioni et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Ehrlich, Beiträge zur Theorie und Praxis der histologischen Färbung, University of Leipzig, Leipzig, Germany, 1878.
  2. D. L. Wyles, “Antiviral resistance and the future landscape of hepatitis C virus infection therapy,” The Journal of Infectious Diseases, vol. 207, supplement 1, pp. S33–S39, 2013. View at Publisher · View at Google Scholar
  3. N. Gupta, B. M. Limbago, J. B. Patel, and A. J. Kallen, “Carbapenem-resistant enterobacteriaceae: epidemiology and prevention,” Clinical Infectious Diseases, vol. 53, no. 1, pp. 60–67, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. M. S. Butler and M. A. Cooper, “Screening strategies to identify new antibiotics,” Current Drug Targets, vol. 13, no. 3, pp. 373–387, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. R. L. Finley, P. Collignon, D. G. Larsson et al., “The scourge of antibiotic resistance: the important role of the environment,” Clinical Infectious Diseases, vol. 57, no. 5, pp. 704–710, 2013. View at Publisher · View at Google Scholar
  6. G. Kohler and C. Milstein, “Continuous cultures of fused cells secreting antibody of predefined specificity,” Nature, vol. 256, no. 5517, pp. 495–497, 1975. View at Google Scholar · View at Scopus
  7. J. L. Teillaud, “From whole monoclonal antibodies to single domain antibodies: think small,” Methods in Molecular Biology, vol. 911, pp. 3–13, 2012. View at Publisher · View at Google Scholar
  8. N. Clementi, N. Mancini, L. Solforosi, M. Castelli, M. Clementi, and R. Burioni, “Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogens,” International Journal of Molecular Sciences, vol. 13, no. 7, pp. 8273–8292, 2012. View at Publisher · View at Google Scholar
  9. X.-R. Jiang, A. Song, S. Bergelson et al., “Advances in the assessment and control of the effector functions of therapeutic antibodies,” Nature Reviews Drug Discovery, vol. 10, no. 2, pp. 101–111, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Mancini, L. Solforosi, N. Clementi, D. De Marco, M. Clementi, and R. Burioni, “A potential role for monoclonal antibodies in prophylactic and therapeutic treatment of influenza,” Antiviral Research, vol. 92, no. 1, pp. 15–26, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Burioni, M. Perotti, N. Mancini, and M. Clementi, “Perspectives for the utilization of neutralizing human monoclonal antibodies as anti-HCV drugs,” Journal of Hepatology, vol. 49, no. 2, pp. 299–300, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Clementi, E. Criscuolo, M. Castelli, N. Mancini, M. Clementi, and R. Burioni, “Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines,” Viruses, vol. 4, no. 11, pp. 3090–3108, 2012. View at Publisher · View at Google Scholar
  13. N. Clementi, N. Mancini, M. Castelli, M. Clementi, and R. Burioni, “Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools,” Drug Discovery Today, vol. 18, no. 9-10, pp. 464–471, 2013. View at Google Scholar
  14. N. Mancini, M. Clementi, and R. Burioni, “Natalizumab-associated progressive multifocal leukoencephalopathy,” The New England Journal of Medicine, vol. 367, no. 9, pp. 871–872, 2012. View at Google Scholar